Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Erratum to "Patients experiences and social support needs following the diagnosis and initial treatment of acute leukemia - A qualitative study" [Eur. J. Oncol. Nurs. 41 (2019) 49-55].

Nørskov KH, Overgaard D, Lomborg K, Kjeldsen L, Jarden M.

Eur J Oncol Nurs. 2019 Aug 23. pii: S1462-3889(19)30113-9. doi: 10.1016/j.ejon.2019.08.004. [Epub ahead of print] No abstract available.

PMID:
31451374
2.

Patients' experiences and social support needs following the diagnosis and initial treatment of acute leukemia - A qualitative study.

Nørskov KH, Overgaard D, Lomborg K, Kjeldsen L, Jarden M.

Eur J Oncol Nurs. 2019 Aug;41:49-55. doi: 10.1016/j.ejon.2019.05.005. Epub 2019 May 31. Erratum in: Eur J Oncol Nurs. 2019 Aug 23;:.

PMID:
31358257
3.

Hydrochloric acid prolongs the lifetime of central venous catheters in haematologic patients with bacteraemia.

Ahmad A, Moser C, Classen V, Hjerming M, Dahl A, Kjeldsen L, Bjerrum OW.

Dan Med J. 2019 May;66(5). pii: A5544.

PMID:
31066353
4.

Autism spectrum disorders, endocrine disrupting compounds, and heavy metals in amniotic fluid: a case-control study.

Long M, Ghisari M, Kjeldsen L, Wielsøe M, Nørgaard-Pedersen B, Mortensen EL, Abdallah MW, Bonefeld-Jørgensen EC.

Mol Autism. 2019 Jan 9;10:1. doi: 10.1186/s13229-018-0253-1. eCollection 2019.

5.

Addition of the mammalian target of rapamycin inhibitor, everolimus, to consolidation therapy in acute myeloid leukemia: experience from the UK NCRI AML17 trial.

Burnett AK, Das Gupta E, Knapper S, Khwaja A, Sweeney M, Kjeldsen L, Hawkins T, Betteridge SE, Cahalin P, Clark RE, Hills RK, Russell NH; UK NCRI AML Study Group.

Haematologica. 2018 Oct;103(10):1654-1661. doi: 10.3324/haematol.2018.189514. Epub 2018 Jul 5.

6.

One-Stop Dispensing: Hospital Costs and Patient Perspectives on Self-Management of Medication.

Houlind MB, McNulty HBØ, Treldal C, Andersen SL, Huneck Haupt T, Petersen J, Andersen O, Kjeldsen LJ.

Pharmacy (Basel). 2018 May 28;6(2). pii: E46. doi: 10.3390/pharmacy6020046.

7.

Multifaceted Pharmacist-led Interventions in the Hospital Setting: A Systematic Review.

Skjøt-Arkil H, Lundby C, Kjeldsen LJ, Skovgårds DM, Almarsdóttir AB, Kjølhede T, Duedahl TH, Pottegård A, Graabaek T.

Basic Clin Pharmacol Toxicol. 2018 Oct;123(4):363-379. doi: 10.1111/bcpt.13030. Epub 2018 Jun 13. Review.

PMID:
29723934
8.

Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma.

Fridthjof KS, Kampmann P, Dünweber A, Gørløv JS, Nexø C, Friis LS, Nørskov KH, Welinder PC, Moser C, Kjeldsen L, Møller T.

Br J Haematol. 2018 Jun;181(5):637-641. doi: 10.1111/bjh.15249. Epub 2018 Apr 20.

PMID:
29676445
9.

Pharmacist-led interventions improve quality of medicine-related healthcare service at hospital discharge.

Duedahl TH, Hansen WB, Kjeldsen LJ, Graabæk T.

Eur J Hosp Pharm. 2018 Mar;25(e1):e40-e45. doi: 10.1136/ejhpharm-2016-001166. Epub 2017 Jun 19.

10.

Novel variants in Nordic patients referred for genetic testing of telomere-related disorders.

Norberg A, Rosén A, Raaschou-Jensen K, Kjeldsen L, Moilanen JS, Paulsson-Karlsson Y, Baliakas P, Lohi O, Ahmed A, Kittang AO, Larsson P, Roos G, Degerman S, Hultdin M.

Eur J Hum Genet. 2018 Jun;26(6):858-867. doi: 10.1038/s41431-018-0112-8. Epub 2018 Feb 26.

11.

Healthcare professionals' agreement on clinical relevance of drug-related problems among elderly patients.

Bech CF, Frederiksen T, Villesen CT, Højsted J, Nielsen PR, Kjeldsen LJ, Nørgaard LS, Christrup LL.

Int J Clin Pharm. 2018 Feb;40(1):119-125. doi: 10.1007/s11096-017-0572-x. Epub 2017 Dec 16.

PMID:
29248987
12.

Risks of bleeding and thrombosis in intensive care unit patients with haematological malignancies.

Russell L, Holst LB, Kjeldsen L, Stensballe J, Perner A.

Ann Intensive Care. 2017 Dec 11;7(1):119. doi: 10.1186/s13613-017-0341-y.

13.

Investigating the Relative Significance of Drug-Related Problem Categories.

Kjeldsen LJ, Nielsen TRH, Olesen C.

Pharmacy (Basel). 2017 Jun 9;5(2). pii: E31. doi: 10.3390/pharmacy5020031. Review.

14.

Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care.

Kjeldsen LJ, Olesen C, Hansen MK, Nielsen TRH.

Pharmacy (Basel). 2017 May 20;5(2). pii: E28. doi: 10.3390/pharmacy5020028.

15.

Medication errors in pediatric inpatients: a study based on a national mandatory reporting system.

Rishoej RM, Almarsdóttir AB, Christesen HT, Hallas J, Kjeldsen LJ.

Eur J Pediatr. 2017 Dec;176(12):1697-1705. doi: 10.1007/s00431-017-3023-8. Epub 2017 Oct 1.

PMID:
28965285
16.

Three-year follow-up of implementation of evidence-based transfusion practice in a tertiary hospital.

Norgaard A, Stensballe J, de Lichtenberg TH, White JO, Perner A, Wanscher M, Hillingsø J, Holm ML, Mau-Sørensen M, Sillesen H, Kjeldsen L, Bäck C, Nielsen J, Seeberg J, Hansen MB, Johansson PI.

Vox Sang. 2017 Apr;112(3):229-239. doi: 10.1111/vox.12485. Epub 2017 Feb 20.

PMID:
28220499
17.

A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML.

Knapper S, Russell N, Gilkes A, Hills RK, Gale RE, Cavenagh JD, Jones G, Kjeldsen L, Grunwald MR, Thomas I, Konig H, Levis MJ, Burnett AK.

Blood. 2017 Mar 2;129(9):1143-1154. doi: 10.1182/blood-2016-07-730648. Epub 2016 Nov 21.

18.

An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation.

Ferguson P, Hills RK, Grech A, Betteridge S, Kjeldsen L, Dennis M, Vyas P, Goldstone AH, Milligan D, Clark RE, Russell NH, Craddock C; UK NCRI AML Working Group.

Haematologica. 2016 Nov;101(11):1351-1358. Epub 2016 Aug 18.

19.

Improved outcome in acute myeloid leukemia patients enrolled in clinical trials: A national population-based cohort study of Danish intensive chemotherapy patients.

Østgård LS, Nørgaard M, Sengeløv H, Medeiros BC, Kjeldsen L, Overgaard UM, Severinsen MT, Marcher CW, Jensen MK, Nørgaard JM.

Oncotarget. 2016 Nov 1;7(44):72044-72056. doi: 10.18632/oncotarget.12495.

20.

The challenges of outcome research.

Kjeldsen LJ, Nielsen TR, Olesen C.

Int J Clin Pharm. 2016 Jun;38(3):705-8. doi: 10.1007/s11096-016-0293-6. Epub 2016 Apr 2.

PMID:
27039091
21.

Multimodal intervention integrated into the clinical management of acute leukemia improves physical function and quality of life during consolidation chemotherapy: a randomized trial 'PACE-AL'.

Jarden M, Møller T, Christensen KB, Kjeldsen L, Birgens HS, Adamsen L.

Haematologica. 2016 Jul;101(7):e316-9. doi: 10.3324/haematol.2015.140152. Epub 2016 Apr 1. No abstract available.

22.

Estrone sulfate and dehydroepiandrosterone sulfate: Transactivation of the estrogen and androgen receptor.

Bjerregaard-Olesen C, Ghisari M, Kjeldsen LS, Wielsøe M, Bonefeld-Jørgensen EC.

Steroids. 2016 Jan;105:50-8. doi: 10.1016/j.steroids.2015.11.009. Epub 2015 Dec 5.

PMID:
26666359
23.

Early warning and prevention of pneumonia in acute leukemia by patient education, spirometry, and positive expiratory pressure: A randomized controlled trial.

Møller T, Moser C, Adamsen L, Rugaard G, Jarden M, Bøtcher TS, Wiedenbein L, Kjeldsen L.

Am J Hematol. 2016 Mar;91(3):271-6. doi: 10.1002/ajh.24262. Epub 2016 Feb 9.

24.

Improving Medication Adherence in Patients with Hypertension: A Randomized Trial.

Hedegaard U, Kjeldsen LJ, Pottegård A, Henriksen JE, Lambrechtsen J, Hangaard J, Hallas J.

Am J Med. 2015 Dec;128(12):1351-61. doi: 10.1016/j.amjmed.2015.08.011. Epub 2015 Aug 21.

PMID:
26302142
25.

Process- and patient-reported outcomes of a multifaceted medication adherence intervention for hypertensive patients in secondary care.

Hedegaard U, Hallas J, Ravn-Nielsen LV, Kjeldsen LJ.

Res Social Adm Pharm. 2016 Mar-Apr;12(2):302-18. doi: 10.1016/j.sapharm.2015.05.006. Epub 2015 May 18.

PMID:
26088274
26.

A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients.

Burnett AK, Russell NH, Hills RK, Kell J, Cavenagh J, Kjeldsen L, McMullin MF, Cahalin P, Dennis M, Friis L, Thomas IF, Milligan D, Clark RE; UK NCRI AML Study Group.

Blood. 2015 Jun 18;125(25):3878-85. doi: 10.1182/blood-2015-01-623447. Epub 2015 Apr 1.

27.

Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia.

Dennis M, Russell N, Hills RK, Hemmaway C, Panoskaltsis N, McMullin MF, Kjeldsen L, Dignum H, Thomas IF, Clark RE, Milligan D, Burnett AK.

Blood. 2015 May 7;125(19):2923-32. doi: 10.1182/blood-2014-10-608117. Epub 2015 Mar 24.

28.

Optimized patient-trajectory for patients undergoing treatment with high-dose chemotherapy and autologous stem cell transplantation.

Bartels FR, Smith NS, Gørløv JS, Grufstedt HK, Nexø C, Kehlet H, Sjøgren P, Kjeldsen L, Høgdal N.

Acta Oncol. 2015 May;54(5):750-8. doi: 10.3109/0284186X.2014.999872. Epub 2015 Mar 11.

PMID:
25761093
29.

Earlier induction of labour in post term pregnancies--A historical cohort study.

Kjeldsen LL, Sindberg M, Maimburg RD.

Midwifery. 2015 May;31(5):526-31. doi: 10.1016/j.midw.2015.02.003. Epub 2015 Feb 12.

PMID:
25726005
30.

Multifaceted intervention including motivational interviewing to support medication adherence after stroke/transient ischemic attack: a randomized trial.

Hedegaard U, Kjeldsen LJ, Pottegård A, Bak S, Hallas J.

Cerebrovasc Dis Extra. 2014 Dec 11;4(3):221-34. doi: 10.1159/000369380. eCollection 2014 Sep-Dec.

31.

A comparative assessment of the curative potential of reduced intensity allografts in acute myeloid leukaemia.

Russell NH, Kjeldsen L, Craddock C, Pagliuca A, Yin JA, Clark RE, Howman A, Hills RK, Burnett AK; UK NCRI Adult AML Working Party.

Leukemia. 2015 Jul;29(7):1478-84. doi: 10.1038/leu.2014.319. Epub 2014 Nov 7.

PMID:
25376374
32.

[Development of patient-specific issues in relation to medicines is a challenge to all health-care professionals].

Kjeldsen LJ, Axelsen TB, Grønkjær LS, Nielsen TR, Tomsen DV, Væver TJ.

Ugeskr Laeger. 2014 Jun 9;176(24). pii: V11130639. Danish.

PMID:
25352199
33.

Adductor canal blockade for moderate to severe pain after arthroscopic knee surgery: a randomized controlled trial.

Espelund M, Grevstad U, Jaeger P, Hölmich P, Kjeldsen L, Mathiesen O, Dahl JB.

Acta Anaesthesiol Scand. 2014 Nov;58(10):1220-7. doi: 10.1111/aas.12407.

PMID:
25307707
34.

[Gelatinous transformation of the bone marrow caused by excessive physical activity and insufficient calorie intake].

Andersen SA, Salomo L, Ralfkiær E, Kjeldsen L.

Ugeskr Laeger. 2014 Sep 15;176(38). pii: V03140183. Review. Danish.

PMID:
25294206
35.

A national drug related problems database: evaluation of use in practice, reliability and reproducibility.

Kjeldsen LJ, Birkholm T, Fischer H, Graabæk T, Hansen MK, Kibsdal KP, Ravn-Nielsen LV, Truelshøj TH.

Int J Clin Pharm. 2014 Aug;36(4):742-9. doi: 10.1007/s11096-014-9957-2. Epub 2014 Jun 5.

PMID:
24899212
36.

Safe and effective use of medicines for patients with type 2 diabetes - A randomized controlled trial of two interventions delivered by local pharmacies.

Kjeldsen LJ, Bjerrum L, Dam P, Larsen BO, Rossing C, Søndergaard B, Herborg H.

Res Social Adm Pharm. 2015 Jan-Feb;11(1):47-62. doi: 10.1016/j.sapharm.2014.03.003. Epub 2014 Apr 12.

PMID:
24798710
37.

Biomonitoring and hormone-disrupting effect biomarkers of persistent organic pollutants in vitro and ex vivo.

Bonefeld-Jørgensen EC, Ghisari M, Wielsøe M, Bjerregaard-Olesen C, Kjeldsen LS, Long M.

Basic Clin Pharmacol Toxicol. 2014 Jul;115(1):118-28. doi: 10.1111/bcpt.12263. Epub 2014 May 29. Review.

38.

Characterization of drug-related problems identified by clinical pharmacy staff at Danish hospitals.

Kjeldsen LJ, Birkholm T, Fischer H, Graabæk T, Kibsdal KP, Ravn-Nielsen LV, Truelshøj TH.

Int J Clin Pharm. 2014 Aug;36(4):734-41. doi: 10.1007/s11096-014-9939-4. Epub 2014 Apr 16.

PMID:
24736894
39.

Evaluation of a controlled, national collaboration study on a clinical pharmacy service of screening for risk medications.

Kjeldsen LJ, Clemmensen MH, Kronborg C, Hedegaard U, Larsen LH, Yderstræde IO, Nielsen JL, Nielsen TR.

Int J Clin Pharm. 2014 Apr;36(2):368-76. doi: 10.1007/s11096-013-9905-6. Epub 2013 Dec 18.

PMID:
24346818
40.

Patient Activation through Counseling and Exercise--Acute Leukemia (PACE-AL)--a randomized controlled trial.

Jarden M, Møller T, Kjeldsen L, Birgens H, Christensen JF, Bang Christensen K, Diderichsen F, Hendriksen C, Adamsen L.

BMC Cancer. 2013 Oct 2;13:446. doi: 10.1186/1471-2407-13-446.

41.

Do educational meetings and group detailing change adherence to drug formularies in hospitals? A cluster randomized controlled trial.

Plet HT, Kjeldsen LJ, Christensen Rde P, Nielsen GS, Hallas J.

Eur J Clin Pharmacol. 2014 Jan;70(1):109-16.

PMID:
24077960
42.

A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia.

Birgens H, Frederiksen H, Hasselbalch HC, Rasmussen IH, Nielsen OJ, Kjeldsen L, Larsen H, Mourits-Andersen T, Plesner T, Rønnov-Jessen D, Vestergaard H, Klausen TW, Schöllkopf C.

Br J Haematol. 2013 Nov;163(3):393-9. doi: 10.1111/bjh.12541. Epub 2013 Aug 24.

PMID:
23981017
43.

Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial.

Burnett AK, Russell NH, Hills RK, Hunter AE, Kjeldsen L, Yin J, Gibson BE, Wheatley K, Milligan D.

J Clin Oncol. 2013 Sep 20;31(27):3360-8. doi: 10.1200/JCO.2012.47.4874. Epub 2013 Aug 12.

PMID:
23940227
44.

Currently used pesticides and their mixtures affect the function of sex hormone receptors and aromatase enzyme activity.

Kjeldsen LS, Ghisari M, Bonefeld-Jørgensen EC.

Toxicol Appl Pharmacol. 2013 Oct 15;272(2):453-64. doi: 10.1016/j.taap.2013.06.028. Epub 2013 Jul 16.

PMID:
23871939
45.

Adherence to hospital drug formularies and cost of drugs in hospitals in Denmark.

Plet HT, Hallas J, Kjeldsen LJ.

Eur J Clin Pharmacol. 2013 Oct;69(10):1837-43. doi: 10.1007/s00228-013-1540-6. Epub 2013 Jun 14.

PMID:
23765410
46.

Perfluorinated compounds affect the function of sex hormone receptors.

Kjeldsen LS, Bonefeld-Jørgensen EC.

Environ Sci Pollut Res Int. 2013 Nov;20(11):8031-44. doi: 10.1007/s11356-013-1753-3. Epub 2013 Jun 14.

PMID:
23764977
47.

Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review.

Graabaek T, Kjeldsen LJ.

Basic Clin Pharmacol Toxicol. 2013 Jun;112(6):359-73. doi: 10.1111/bcpt.12062. Epub 2013 Apr 6. Review.

48.

Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia.

Gudbrandsdottir S, Birgens HS, Frederiksen H, Jensen BA, Jensen MK, Kjeldsen L, Klausen TW, Larsen H, Mourits-Andersen HT, Nielsen CH, Nielsen OJ, Plesner T, Pulczynski S, Rasmussen IH, Rønnov-Jessen D, Hasselbalch HC.

Blood. 2013 Mar 14;121(11):1976-81. doi: 10.1182/blood-2012-09-455691. Epub 2013 Jan 4.

49.

Outreach visits by clinical pharmacists improve screening for the metabolic syndrome among mentally ill patients.

Kjeldsen LJ, Hansen PS, Kristensen AM, Christensen A, Sørensen CH, Nielsen B.

Nord J Psychiatry. 2013 Aug;67(4):249-57. doi: 10.3109/08039488.2012.732115. Epub 2012 Nov 6.

PMID:
23126478
50.

Drug and therapeutics committees in Danish hospitals: a survey of organization, activities and drug selection procedures.

Plet HT, Hallas J, Nielsen GS, Kjeldsen LJ.

Basic Clin Pharmacol Toxicol. 2013 Apr;112(4):264-9. doi: 10.1111/bcpt.12028. Epub 2012 Dec 20.

Supplemental Content

Loading ...
Support Center